JP2021504446A5 - - Google Patents

Download PDF

Info

Publication number
JP2021504446A5
JP2021504446A5 JP2020545063A JP2020545063A JP2021504446A5 JP 2021504446 A5 JP2021504446 A5 JP 2021504446A5 JP 2020545063 A JP2020545063 A JP 2020545063A JP 2020545063 A JP2020545063 A JP 2020545063A JP 2021504446 A5 JP2021504446 A5 JP 2021504446A5
Authority
JP
Japan
Prior art keywords
nanobiological
composition
composition according
accelerator
phosphocholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020545063A
Other languages
English (en)
Japanese (ja)
Other versions
JP7330994B2 (ja
JPWO2019103998A5 (https=
JP2021504446A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/061935 external-priority patent/WO2019103998A2/en
Publication of JP2021504446A publication Critical patent/JP2021504446A/ja
Publication of JP2021504446A5 publication Critical patent/JP2021504446A5/ja
Publication of JPWO2019103998A5 publication Critical patent/JPWO2019103998A5/ja
Priority to JP2023130072A priority Critical patent/JP7772748B2/ja
Application granted granted Critical
Publication of JP7330994B2 publication Critical patent/JP7330994B2/ja
Priority to JP2025187368A priority patent/JP2026015394A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020545063A 2017-11-21 2018-11-20 治療用ナノ生物学的組成物による訓練免疫の促進 Active JP7330994B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023130072A JP7772748B2 (ja) 2017-11-21 2023-08-09 治療用ナノ生物学的組成物による訓練免疫の促進
JP2025187368A JP2026015394A (ja) 2017-11-21 2025-11-06 治療用ナノ生物学的組成物による訓練免疫の促進

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762589054P 2017-11-21 2017-11-21
US62/589,054 2017-11-21
PCT/US2018/061935 WO2019103998A2 (en) 2017-11-21 2018-11-20 Promoting trained immunity with therapeutic nanobiologic compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023130072A Division JP7772748B2 (ja) 2017-11-21 2023-08-09 治療用ナノ生物学的組成物による訓練免疫の促進

Publications (4)

Publication Number Publication Date
JP2021504446A JP2021504446A (ja) 2021-02-15
JP2021504446A5 true JP2021504446A5 (https=) 2023-05-23
JPWO2019103998A5 JPWO2019103998A5 (https=) 2023-05-23
JP7330994B2 JP7330994B2 (ja) 2023-08-22

Family

ID=66630773

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020545063A Active JP7330994B2 (ja) 2017-11-21 2018-11-20 治療用ナノ生物学的組成物による訓練免疫の促進
JP2023130072A Active JP7772748B2 (ja) 2017-11-21 2023-08-09 治療用ナノ生物学的組成物による訓練免疫の促進
JP2025187368A Pending JP2026015394A (ja) 2017-11-21 2025-11-06 治療用ナノ生物学的組成物による訓練免疫の促進

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023130072A Active JP7772748B2 (ja) 2017-11-21 2023-08-09 治療用ナノ生物学的組成物による訓練免疫の促進
JP2025187368A Pending JP2026015394A (ja) 2017-11-21 2025-11-06 治療用ナノ生物学的組成物による訓練免疫の促進

Country Status (7)

Country Link
US (4) US20200261591A1 (https=)
EP (1) EP3713548A4 (https=)
JP (3) JP7330994B2 (https=)
CN (1) CN111971028A (https=)
AU (2) AU2018370828B2 (https=)
CA (1) CA3082830A1 (https=)
WO (1) WO2019103998A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4014967A1 (en) 2016-04-29 2022-06-22 Icahn School of Medicine at Mount Sinai Targeting the innate immunesystem to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis
US20230266321A1 (en) * 2020-06-25 2023-08-24 Icahn School Of Medicine At Mount Sinai Live cell engagement assay
CN118459539B (zh) * 2021-03-19 2026-01-06 生物治疗探索股份有限公司 用于调节训练免疫的化合物及其使用方法
IT202100014747A1 (it) * 2021-06-07 2022-12-07 Consiglio Nazionale Ricerche Derivati sterolici come nuovi ligandi del recettore dectina-1 nel trattamento terapeutico di patologie correlate a tale recettore
CA3222851A1 (en) 2021-06-22 2022-12-29 Roy VAN DER MEEL Nucleic acid containing nanoparticles
WO2023192956A2 (en) * 2022-03-31 2023-10-05 Icahn School Of Medicine At Mount Sinai Sphingolipid-loaded nanobiologics for immune regulation
JP2025518282A (ja) 2022-06-03 2025-06-12 バイオ－トリップ ベーフェー 核酸送達のための多価分子に基づく脂質ナノ粒子

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101096386A (zh) * 2007-06-05 2008-01-02 复旦大学 Dectin-1与热休克蛋白Hsp60聚合物及其编码核酸和应用
CN101903018B (zh) * 2007-10-17 2012-09-05 韩国科学技术院 用于递送核酸基因的ldl样阳离子纳米微粒、其制备方法以及使用其递送核酸基因的方法
CN105903029A (zh) * 2007-12-12 2016-08-31 大学健康网络 高密度脂蛋白样肽磷脂支架（“hpps”）纳米颗粒
US10525152B2 (en) * 2009-10-09 2020-01-07 Signablok, Inc. Methods and compositions for targeted imaging
WO2012026712A2 (ko) * 2010-08-23 2012-03-01 주식회사 강스템홀딩스 Ｎｏｄ２의 아고니스트를 처리한 줄기세포 또는 그 배양물을 포함하는 면역질환 또는 염증질환의 예방 또는 치료용 약학조성물
KR20160093012A (ko) * 2013-11-05 2016-08-05 코그네이트 바이오서비시즈, 인코포레이티드 암 치료를 위한 체크포인트 억제제 및 치료제의 배합물
WO2016154544A1 (en) * 2015-03-25 2016-09-29 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
CN106714836A (zh) * 2015-06-05 2017-05-24 H·李·莫菲特癌症中心研究有限公司 Gm‑csf/cd40l疫苗和检查点抑制剂联合治疗
WO2017024312A1 (en) * 2015-08-06 2017-02-09 Autotelic Llc Phospholipid-cholesteryl ester nanoformulations and related methods

Similar Documents

Publication Publication Date Title
JP2021504446A5 (https=)
Yu et al. Near-infrared photoactivatable semiconducting polymer nanocomplexes with bispecific metabolism interventions for enhanced cancer immunotherapy
Zhang et al. Oral delivery of nanoparticles loaded with ginger active compound, 6-shogaol, attenuates ulcerative colitis and promotes wound healing in a murine model of ulcerative colitis
Pan et al. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy
Kim et al. Immune-triggered cancer treatment by intestinal lymphatic delivery of docetaxel-loaded nanoparticle
Shahzad et al. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles
KR20150064097A (ko) 암을 치료하는 방법
CN103083239A (zh) 一种蟾毒灵脂质体及其制备方法和应用
Deng et al. Novel T7-modified pH-responsive targeted nanosystem for co-delivery of docetaxel and curcumin in the treatment of esophageal cancer
Groer et al. Intratumoral cancer chemotherapy with a carrier-based immunogenic cell-death eliciting platinum (IV) Agent
CN109692326A (zh) 一种蜂毒脂质纳米颗粒的应用
Song et al. Dual-targeting nanovesicles enhance specificity to dynamic tumor cells in vitro and in vivo via manipulation of αvβ3-ligand binding
AbouSamra Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications
CN109200292B (zh) 具有治疗阿尔茨海默病功效的纳米复合体及其制备方法与应用
Qian et al. Evaluation of cisplatin-hydrogel for improving localized antitumor efficacy in gastric cancer
Huang et al. Ultrasound-mediated FAK-targeted nano-sapper for tumor extracellular matrix remodeling to potentiate cancer immunotherapy
WO2004053067A2 (en) Methods for inhibiting cancer and scar formation
Lu et al. Nanoparticle-based therapeutics to overcome obstacles in the tumor microenvironment of hepatocellular carcinoma
Li et al. Ultralong circulating choline phosphate liposomal nanomedicines for cascaded chemo-radiotherapy
CN106606783B (zh) 一种靶向共递释光敏剂与化疗药物的药物递释系统
Jin et al. Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer
US10537531B2 (en) Casein coated drug-loaded iron oxide nanoparticles
CN114222580B (zh) 一种预防和/或治疗卵巢癌的多肽药物及其用途
CN110974804B (zh) p53信使RNA纳米粒及其制备方法和在制备治疗肿瘤药物中的应用
Zhao et al. Autophagy modulation and synergistic therapy to Combat Multidrug resistance breast Cancer using hybrid cell membrane nanoparticles